Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
J Health Care Poor Underserved ; 33(3): 1177-1186, 2022.
Article in English | MEDLINE | ID: mdl-36245156

ABSTRACT

OBJECTIVE: The study aimed to evaluate differences in age, gender, race, and ethnicity between a population served by a street psychiatry team and the local community of people experiencing unsheltered homelessness in order to identify intersectional inequities in care. METHODS: We tested for bivariate associations between patient affiliation and age, gender, race, and ethnicity using a Welch two sample t-test for the continuous term (age) and Pearson's chi-squared test with Yates' continuity correction for the categorical terms (gender, race, and ethnicity). RESULTS: The CMHC Street Psychiatry Team served a population (N = 200) that was significantly older (p<.001) and composed of proportionally fewer women (p = .010) and people of color (p<.001) than the local population experiencing unsheltered homelessness (N = 944). CONCLUSIONS: This process of critical evaluation identified disparities in service provision which prompted re-evaluation of services to target efforts to those most at risk of marginalization.


Subject(s)
Ill-Housed Persons , Mental Health Services , Ethnicity , Female , Ill-Housed Persons/psychology , Humans , Mental Health , Social Problems
3.
Bipolar Disord ; 24(4): 447-450, 2022 06.
Article in English | MEDLINE | ID: mdl-35124893

ABSTRACT

Lithium levels are often checked in the inpatient setting when a patient has clear indications of acute kidney injury. Lithium levels can become supratherapeutic in COVID-19 infection even after normalization of creatinine. Lithium levels should be checked routinely in patients with COVID-19 infection in order to avoid supratherapeutic levels.


Subject(s)
Acute Kidney Injury , Bipolar Disorder , COVID-19 , Creatinine , Humans , Lithium/therapeutic use
4.
Community Ment Health J ; 57(8): 1427-1434, 2021 11.
Article in English | MEDLINE | ID: mdl-34059983

ABSTRACT

"Street psychiatry" is an innovative model that serves people experiencing unsheltered homelessness, a vulnerable population with increased rates of mental illness and substance use disorders. Through community-based delivery of mental health and addiction treatment, street psychiatry helps the street-dwelling population overcome barriers to accessing care through traditional routes. Throughout the United States, street psychiatry programs have arisen in multiple cities, often in partnership with street medicine programs. We discuss the philosophy of street psychiatry, document operational highlights involved in the development of a street psychiatry program in New Haven, CT, suggest key ingredients to implementing a street psychiatry program, and explore challenges and future frontiers. Street psychiatry is an effective person-centered model of service delivery with the potential to be applied in a variety of urban settings to serve people experiencing street homelessness.


Subject(s)
Ill-Housed Persons , Psychiatry , Substance-Related Disorders , Humans , Substance-Related Disorders/therapy , Tomography, X-Ray Computed , United States
5.
Biol Psychiatry ; 90(4): e23-e26, 2021 08 15.
Article in English | MEDLINE | ID: mdl-34001372

ABSTRACT

Retraction notice to: "Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin" by Lindsay S. McAlpine, Brooke Lifland, Joseph R. Check, Gustavo A. Angarita, Thomas T. Ngo, Samuel J. Pleasure, Michael R. Wilson, Serena S. Spudich, Shelli F. Farhadian, and Christopher M. Bartley (Biol Psychiatry 2021; 90:e23-e26); https://doi.org/10.1016/j.biopsych.2021.03.033. This article has been retracted at the request of corresponding author Christopher Bartley, with agreement from all authors and with approval from Biological Psychiatry Editor John H. Krystal, M.D. See Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). After this article was published, the authors determined that two cerebrospinal fluid (CSF) samples were inadvertently confused, resulting in publication of the wrong COVID-19 patient's immunostaining data. The authors determined that the two CSF samples came from COVID-19 patients with sequential case identifiers (i.e., one identifier ended in a "5" and the other in a "6"). To determine whether the published immunostaining results were produced by CSF from another COVID-19 patient, the authors reperformed the mouse brain immunostaining experiments using additional aliquots of stored CSF from the two research participants in question, as well as with the remaining CSF that had been used in the publication. After repeating the immunostaining with these CSF samples, two blinded raters were able to state unequivocally that the CSF samples from the two COVID-19 patients had been confused. Therefore, while the clinical features of the case report are accurate and unaffected, the research data belong to another COVID-19 research participant, not the one described in the published case report. The authors voluntarily informed the Journal of this honest error upon its discovery. All authors agree to retract this paper and sincerely apologize for having allowed the incorrect images to be published with this case report. To avoid misinterpretation of the research findings, both the editors and authors concur that the only proper course of action was to retract this version of the paper. However, this COVID-19 psychosis case remains of clinical interest because of the patient's clear response to immunotherapy. Therefore, the authors are revising the paper, which the Journal will consider further for publication.


Subject(s)
COVID-19 , Psychotic Disorders , Autoantibodies , Humans , Immunoglobulins, Intravenous , Psychotic Disorders/drug therapy , SARS-CoV-2
6.
Adm Policy Ment Health ; 45(6): 979-987, 2018 11.
Article in English | MEDLINE | ID: mdl-29779180

ABSTRACT

Clinical pathways are known to improve the value of health care in medical and surgical settings but have been rarely studied in the psychiatric setting. This study examined the association between level of adherence to an adolescent depressive disorders inpatient clinical pathway and length of stay (LOS), cost, and readmissions. Patients in the high adherence category had significantly longer LOS and higher costs compared to the low adherence category. There was no difference in the odds of 30-day emergency department return visits or readmissions. Understanding which care processes within the pathway are most cost-effective for improving patient-centered outcomes requires further investigation.


Subject(s)
Critical Pathways , Depressive Disorder/therapy , Health Care Costs , Length of Stay/statistics & numerical data , Patient Readmission/statistics & numerical data , Adolescent , Child , Cohort Studies , Cost-Benefit Analysis , Female , Humans , Male , Patient Acceptance of Health Care , Patient Outcome Assessment , Retrospective Studies
7.
Acad Pediatr ; 18(4): 376-383, 2018.
Article in English | MEDLINE | ID: mdl-29229566

ABSTRACT

OBJECTIVES: Monitoring patient-centered health outcomes after hospital discharge is important for identifying patients experiencing poor recovery after surgery. Utilizing parent reports may improve the feasibility of monitoring recovery when children are not available to provide self-report. We therefore aimed to examine agreement between parent and child reports of child pain and health-related quality of life (HRQOL) in children after hospital discharge from inpatient surgery. METHODS: A total of 295 children aged 8 to 18 years and their parents reported on child pain intensity using an 11-point numerical rating scale and on HRQOL using the 0- to 100-point Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales by phone or online, 4 to 8 weeks after surgery. Agreement between parent and child ratings was assessed by absolute discrepancy scores, Pearson product-moment correlations, 2-way mixed effects intraclass correlation coefficient models, and linear regression models. RESULTS: We found good to excellent agreement between child and parent reports of pain intensity and HRQOL. Average absolute discrepancy scores of pain intensity and HRQOL were 0.6 and 7.8 points, respectively. Pearson product-moment correlation coefficients were 0.74 and 0.80, and intraclass correlation coefficients were 0.72 and 0.79, for pain intensity and HRQOL, respectively. Regression coefficients for models examining pain intensity and HRQOL were 0.93 to 0.98 and 1.0, respectively. CONCLUSIONS: Although child and parent reports may both contribute important information, parent report is a valid proxy for child self-reported pain intensity and HRQOL after discharge from inpatient pediatric surgery, which may prove important for better understanding pain experiences and intervention needs.


Subject(s)
Health Status , Pain, Postoperative/physiopathology , Parents , Quality of Life , Self Report , Adolescent , Child , Female , Humans , Linear Models , Male , Pain Measurement
SELECTION OF CITATIONS
SEARCH DETAIL
...